Doctors shine light on deadly brain tumors during surgery
NCT ID NCT03048240
Summary
This small pilot study tested whether adding light-activated therapy during brain tumor surgery is safe and practical. Researchers gave 10 glioblastoma patients a special drug that makes cancer cells sensitive to light, then used laser light during surgery to potentially kill remaining tumor cells. The study aimed to see if this combined approach could be done safely alongside standard surgery and radiation/chemotherapy treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hôpital Roger Salengro, CHRU
Lille, France
Conditions
Explore the condition pages connected to this study.